PMA supplement
P850048 S012: TANDEM-R PSA & TANDEM-E PSA IMMUNOENZYMETRIC ASSAY
FDA PMA supplement · Normal 180 Day Track · Beckman Coulter, Inc.
Key facts
| Original PMA | P850048 |
|---|---|
| Supplement number | S012 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Change Design/Components/Specifications/Material |
| Trade name | TANDEM-R PSA & TANDEM-E PSA IMMUNOENZYMETRIC ASSAY |
| Generic name | PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS |
| Applicant | Beckman Coulter, Inc. |
| Product code | LTJ |
| Received date | Oct 27, 1995 |
| Decision date | May 3, 1996 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: